| P50 | author | Stefan K Solntsev | Q56224030 |
| | Brian L Frey | Q88173747 |
| | Zach Rolfs | Q88790543 |
| P2093 | author name string | Lloyd M Smith | |
| | Michael R Shortreed | |
| P2860 | cites work | The PeptideAtlas project | Q25257813 |
| | WebLogo: A Sequence Logo Generator | Q27860646 |
| | PEAKS: powerful software for peptide de novo sequencing by tandem mass spectrometry | Q28209613 |
| | The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013 | Q28710185 |
| | Universal sample preparation method for proteome analysis | Q29615662 |
| | Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation | Q30002365 |
| | Application of de Novo Sequencing to Large-Scale Complex Proteomics Data Sets | Q31035849 |
| | Sequence-specific retention calculator. Algorithm for peptide retention prediction in ion-pair RP-HPLC: application to 300- and 100-A pore size C18 sorbents | Q33263558 |
| | Global Post-Translational Modification Discovery | Q33551556 |
| | The 20S proteasome splicing activity discovered by SpliceMet | Q33627497 |
| | Pathways of antigen processing | Q33631854 |
| | An antigenic peptide produced by reverse splicing and double asparagine deamidation | Q34192290 |
| | An antigenic peptide produced by peptide splicing in the proteasome | Q34303301 |
| | An antigen produced by splicing of noncontiguous peptides in the reverse order. | Q34564542 |
| | Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules | Q35786206 |
| | Global Identification of Protein Post-translational Modifications in a Single-Pass Database Search | Q36272452 |
| | A proteomics search algorithm specifically designed for high-resolution tandem mass spectra | Q36650680 |
| | Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes | Q36769053 |
| | Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion | Q36945852 |
| | Combining results of multiple search engines in proteomics | Q37160902 |
| | MHC class I-associated peptides derive from selective regions of the human genome | Q37452154 |
| | A large fraction of HLA class I ligands are proteasome-generated spliced peptides. | Q38730967 |
| | The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer | Q38753386 |
| | MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry-based proteomics | Q38844572 |
| | A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimming. | Q39031562 |
| | Origin of Disagreements in Tandem Mass Spectra Interpretation by Search Engines. | Q39444180 |
| | Splicing of distant peptide fragments occurs in the proteasome by transpeptidation and produces the spliced antigenic peptide derived from fibroblast growth factor-5. | Q39739694 |
| | Post-Translational Peptide Splicing and T Cell Responses | Q40083920 |
| | Immune recognition of a human renal cancer antigen through post-translational protein splicing. | Q40599136 |
| | Peptide Splicing in the Proteasome Creates a Novel Type of Antigen with an Isopeptide Linkage. | Q41837849 |
| | The SysteMHC Atlas project | Q41990341 |
| | Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens. | Q46398502 |
| | The role of mass spectrometry and proteogenomics in the advancement of HLA epitope prediction | Q47190955 |
| | Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy? | Q47221163 |
| | NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data | Q47696633 |
| | pDeep: Predicting MS/MS Spectra of Peptides with Deep Learning. | Q48049267 |
| | Analysis of the resolution limitations of peptide identification algorithms | Q49045543 |
| | An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse. | Q51350685 |
| | Enhanced Global Post-translational Modification Discovery with MetaMorpheus. | Q53834938 |
| | A method for reducing the time required to match protein sequences with tandem mass spectra | Q79163113 |
| | CharmeRT: Boosting Peptide Identifications by Chimeric Spectra Identification and Retention Time Prediction | Q88971547 |
| | Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome | Q91254308 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 349-358 | |
| P577 | publication date | 2018-10-31 | |
| P1433 | published in | Journal of Proteome Research | Q3186939 |
| P1476 | title | Global Identification of Post-Translationally Spliced Peptides with Neo-Fusion | |
| P478 | volume | 18 | |